Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;204(Pt C):112314.
doi: 10.1016/j.envres.2021.112314. Epub 2021 Nov 2.

Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: A global analysis

Affiliations

Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: A global analysis

Mario Coccia. Environ Res. 2022 Mar.

Abstract

Coronavirus disease 2019 (COVID-19) continues to be a pandemic threat that is generating a constant state of alert in manifold countries. One of the strategies of defense against infectious diseases (e.g., COVID-19) is the vaccinations that decrease the numbers of infected individuals and deaths. In this context, the optimal level of vaccination for COVID-19 is a basic point to control this pandemic crisis in society. The study here,-using data of doses of vaccines administered per 100 inhabitants, confirmed cases and case fatality ratio of COVID-19 between countries (N=192) from March to May 2021,- clarifies the optimal levels of vaccination for reducing the number of infected individuals and, consequently, the numbers of deaths at global level. Findings reveal that the average level of administering about 80 doses of vaccines per 100 inhabitants between countries can sustain a reduction of confirmed cases and number of deaths. In addition, results suggest that an intensive vaccination campaign in the initial phase of pandemic wave leads to a lower optimal level of doses administered per 100 inhabitants (roughly 47 doses of vaccines administered) for reducing infected individuals; however, the growth of pandemic wave (in May, 2021) moves up the optimal level of vaccines to about 90 doses for reducing the numbers of COVID-19 related infected individuals. All these results here could aid policymakers to prepare optimal strategies directed to a rapid COVID-19 vaccination rollout, before the takeoff of pandemic wave, to lessen negative effects of pandemic crisis on environment and socioeconomic systems.

Keywords: COVID-19 vaccine; Crisis management; Herd immunity; Public health; Vaccination campaign.

PubMed Disclaimer

Conflict of interest statement

The author, Mario Coccia, declares that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Relation of confirmed cases/population (%) on doses of vaccines from March to May 2021 between countries based on quadratic model [1].

References

    1. Abbasi J. COVID-19 and mRNA vaccines-first large test for a new approach. J. Am. Med. Assoc. 2020;324(12):1125–1127. doi: 10.1001/jama.2020.16866. - DOI - PubMed
    1. Abuza Z. The Diplomat; 2020. Explaining Successful (And Unsuccessful) COVID-19 Responses in Southeast Asia.https://thediplomat.com/2020/04/explaining-successful-and-unsuccessfulco... Retrieved.
    1. Akamatsu T., Nagae T., Osawa M., Satsukawa K., Sakai T., Mizutani D. Model-based analysis on social acceptability and feasibility of a focused protection strategy against the COVID-19 pandemic. Sci. Rep. 2021;11(1) doi: 10.1038/s41598-021-81630-9. 2003. - DOI - PMC - PubMed
    1. Aldila D., Samiadji B.M., Simorangkir G.M., Khosnaw S.H.A., Shahzad M. Impact of early detection and vaccination strategy in COVID-19 eradication program in Jakarta, Indonesia. BMC Res. Notes. 2021;14(1):132. - PMC - PubMed
    1. Anand U., Cabreros C., Mal J., Ballesteros F., Jr., Sillanpää M., Tripathi V., Bontempi E. Novel coronavirus disease 2019 (COVID-19) pandemic: from transmission to control with an interdisciplinary vision. Environ. Res. 2021;197 doi: 10.1016/j.envres.2021.111126. - DOI - PMC - PubMed

Substances